"Retina Associates of Cleveland is the largest group practice of ophthalmologists in Ohio who specialize in the medical and surgical treatment of diseases of the retina, including age-related macular degeneration (AMD), diabetic retinopathy, flashes and floaters, and retinal detachment. We have multiple convenient neighborhood offices across NE Ohio to serve you. Calling 1-800-4-RETINA will connect you with our Beachwood office to help set up an appointment in a location near you. For information about our doctors, our practice, our clinical studies, or for educational information about retina diseases, please visit our website."

During the past decade, Retina Associates of Cleveland conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Associates of Cleveland" #1 sponsor was "Kodiak Sciences Inc" with 2 trials, followed by "Aerpio Therapeutics" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Johns Hopkins University" with 1 trials sponsored and "Merck Sharp & Dohme LLC" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Associates of Cleveland" #1 collaborator was "National Eye Institute (NEI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Retina Associates of Cleveland" are "Macular Degeneration" (3 trials), "Age Related Macular Degeneration" (1 trials), "Age-Related Maculopathy" (1 trials), "Choroidal Neovascularization" (1 trials) and "Macular Edema" (1 trials). Many other conditions were trialed in "Retina Associates of Cleveland" in a lesser frequency.

Most popular intervention types in "Retina Associates of Cleveland" are "Drug" (7 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (2 trials), "KSI-301" (2 trials), "Sham Procedure" (2 trials), "AKB-9778" (1 trials) and "Bevasiranib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Associates of Cleveland" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Retina Associates of Cleveland". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Retina Associates of Cleveland, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Associates of Cleveland, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".